Adult and Pediatric Clinical Trials of Sublingual Immunotherapy in the USA Dai Park; Nora Daher; Michael S Blaiss Disclosures Expert Rev Clin Immunol. 2012;8 (6):557-564.

Two of the goals of that program are to generate a detailed wiring diagram for the complete mouse brain, and to map long-distance connections between different areas of the human brain.

Scientists complete largest wiring diagram and functional map of the brain to date The MICrONS Project is considered the most complicated neuroscience experiment ever attempted Date: April 9, 2025 ...

Researchers called for a literature review comparing diagrams and other written information about how patients should be positioned when they receive epinephrine from an autoinjector.

Salivary gland problems can cause dry mouth, swelling, pain, or infection, often due to blockages, infections, or autoimmune disorders like Sjögren's syndrome.

Doctors recommend salivary gland surgery to remove tumors or treat infections or inflammation. Learn about the procedure, complications, and recovery.

Aquestive Therapeutics expects to finish its final supportive study of its Anaphylm sublingual epinephrine film for the treatment of anaphylaxis by the end of 2024.Epinephrine is traditionally ...

The diagrams have been so successful that it can be hard to remember that our cells are not, in fact, filled with colorful ribbons and broad arrows. The Face of Proteins The pencil smudges on ...

There are hundreds of types of salivary gland cancer -- —most are extremely rare. Learn about how they’re discovered, diagnosed, and treated.

The sublingual glands produce very little saliva—only between 3% and 5% of the total volume—and make secretions composed predominantly of mucus, a slippery liquid that lubricates and protects organs.

Salivary gland cancer is a rare disease where cancerous cells form in the tissues of the salivary glands. Signs & Symptoms These are signs of salivary gland cancer: Fluid draining from the ear A lump ...

Investors are betting sublingual drug delivery can unlock the potential of a psychedelic, pumping $60 million into Lusaris Therapeutics to support clinical trials of a depression candidate. The ...